πŸ‡ΊπŸ‡Έ FDA
Patent

US 11590116

Substituted pyridines and methods of use

granted A61KA61K31/444A61K31/4709

Quick answer

US patent 11590116 (Substituted pyridines and methods of use) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/444, A61K31/4709, A61K31/496, A61K31/4985